Ifosfamide/etoposide and mesna uroprotection in advanced breast cancer

Cancer Chemotherapy and Pharmacology
C ManegoldM Kaufmann

Abstract

The object of the study was to evaluate the effectiveness of ifosfamide/etoposide and mesna therapy in advanced breast cancer. A total of 44 patients with breast cancer were included in the trial. Eligibility criteria included measurable, refractory disease; prior anthracycline therapy (or its contraindication); a life expectancy of at least 3 months; and adequate hepatic, renal, CNS and bone marrow function. All patients were less than or equal to 70 years of age and had a Karnofsky performance status of greater than or equal to 50%. There were 36 evaluable cases. Sites of metastatic disease included bone (19), skin (18), liver (9), lung (14), lymph node (19), and miscellaneous (7). Treatment consisted of 1,500 mg/m2 ifosfamide given i.v. on days 1-5, 120 mg/m2 etoposide given i.v. on days 1-3, and 400 mg i.v. mesna given with and at 4 and 8 h after ifosfamide. Cycles were repeated every 28 days. Initial doses were reduced by 25% or 50% in patients who had previously undergone both chemotherapy and radiotherapy. A median of 4 cycles (range, 2-8) were given. The myelotoxicity was marked: WHO grades 3/4 leukopenia (n = 37), grades 3/4 thrombocytopenia (n = 12), and grades 2/3 anemia (n = 13). Due to myelotoxicity, dose reduction...Continue Reading

References

Apr 3, 1976·British Medical Journal·C BrambillaG Bonadonna
Jul 1, 1986·European Journal of Cancer & Clinical Oncology·C A MeanwellG Blackledge
Jan 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B M WheelerL H Einhorn
Mar 1, 1987·European Journal of Cancer & Clinical Oncology·V H BramwellR Sylvester
Jan 1, 1986·Cancer Chemotherapy and Pharmacology·L H Einhorn, P J Loehrer
Mar 1, 1985·Cancer Treatment Reviews·W P BradeM Varini
Jan 1, 1984·Journal of Cancer Research and Clinical Oncology·M TakeuchiS Odashima

❮ Previous
Next ❯

Citations

Jan 1, 1994·Breast Cancer Research and Treatment·M MillwardB Cantwell
Jan 1, 1991·Journal of Cancer Research and Clinical Oncology·W P BradeC E Araujo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.